Sign in / Join Now
ETFs & Funds
Joseph P. Porter
stops its inotuzumab trials for non-Hodgkin's Lymphoma; trials still planned for Leukemia. Look for bad-news drop.
Add a reply...
Latest StockTalks »
people get PFE breaking news and analysis by email alert.
Get email alerts on PFE »
Get latest price
From other sites
Analyst Reports for AT&T, Pfizer & General Mills
at Zacks.com (Tue, 12:36PM)
A CEO's primer on how to manage under pressure
at Financial Times (Mon, 4:00AM)
Pfizer's Medivation Receives FDA Approval For Prostate Cancer Drug XTANDI
at Benzinga (Fri, 3:52PM)
The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals
at Zacks.com (Fri, 9:30AM)
Zacks Market Edge Highlights: Pfizer, Netflix, Baidu, Johnson & Johnson and Domino's Pizza
at Zacks.com (Thu, 9:30AM)